Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits
-
* Corresponding author: Evangelia Patsavoudi epatsavoudi@pasteur.gr
BMC Cell Biology 2010, 11:51 doi:10.1186/1471-2121-11-51
Accesses
- Last 30 days: 57 accesses
- Last 365 days: 756 accesses
- All time: 2085 accesses